Latest Prescription Drugs news
ENDO: Fezolinetant Cuts Vasomotor Symptoms in Menopause
posted June 14th
by modernClinician Editorial Team
by modernClinician Editorial Team
New ALS Drug Approved in Canada While Still Under FDA Review
posted June 13th
by modernClinician Editorial Team
by modernClinician Editorial Team
RAAS Inhibitors May Cut Risk for Rupture in Brain Aneurysm
posted June 10th
by modernClinician Editorial Team
by modernClinician Editorial Team
New Drug Launch Prices Increasing Exponentially Each Year
posted June 9th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Treatment Satisfaction Higher for Patients With RA Choosing Their Own Treatment .jpg)
Most Specialty Oral Anticancer Meds for Blood Cancers Are Initially Rejected by Insurers 
Drug Interactions Reducing Contraceptive Effectiveness Common in Epilepsy 
1 in 3 With Lupus Take Supplements, Medications With Potential for Interactions Related Articles
Holding DMARDs at Time of COVID-19 Vaccine Not Warranted in Those With Inflammatory Arthritis 
2013 to 2024 Saw Decrease in Benzodiazepine Prescribing 
GLP-1 Receptor Agonists, SGLT-2is Slow Renal Function Decline in T2D With Albuminuria 
Polypharmacy of Prescription Medications Increased for U.S. Older Adults Monthly Specialist Briefings
Stay Connected
